Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heweiyangxue Huacai Formula for cancer-related fatigue in non-small cell lung cancer
ChiCTR2400083694Phase 2Not yet recruiting
- Sponsor
- Yueyang Hospital of Integrated Traditional Chinese and Western Medicine
- Start
- Apr 2024
- Countries
- 1
01
Overview
Phase 2, randomised trial of Heweiyangxue Huacai Formula in non-small cell lung cancer (NSCLC) and cancer-related fatigue (CRF) (2 arms), sponsored by Yueyang Hospital of Integrated Traditional Chinese and Western Medicine. Primary endpoint: Piper’s Fatigue Scale. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
Heweiyangxue Huacai Formula
03
Conditions
non-small cell lung cancer (NSCLC)cancer-related fatigue (CRF)
Beyond the preview
Go deeper on ChiCTR2400083694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400083694.